Display options
Share it on

Life (Basel). 2021 Jun 23;11(7). doi: 10.3390/life11070599.

Stress-Related Regulation Is Abnormal in the Psoriatic Uninvolved Skin.

Life (Basel, Switzerland)

Renáta Bozó, Judit Danis, Lili Borbála Flink, Dániel László Vidács, Lajos Kemény, Zsuzsanna Bata-Csörgő

Affiliations

  1. Department of Dermatology and Allergology, University of Szeged, 6720 Szeged, Hungary.
  2. HCEMM-USZ Skin Research Group, 6720 Szeged, Hungary.
  3. MTA-SZTE Dermatological Research Group, Eötvös Loránd Research Network, 6720 Szeged, Hungary.

PMID: 34201431 PMCID: PMC8303303 DOI: 10.3390/life11070599

Abstract

Keratinocyte stress-response of the uninvolved psoriatic epidermis is known to be altered compared to healthy cells. Therefore, we aimed to reveal potential mechanisms underlying this alteration. We compared the expression of annotated cell-stress-related proteins between uninvolved psoriatic and healthy skin using the protein array method. Data were analyzed by the Reactome over-representation test. We found that p27/CDKN1B and cytochrome C showed at least a two-fold increase, while cyclooxygenase-2, indolamine-2,3-dioxygenase-1, serum paraoxonase 1, serum paraoxonase 3, serine-46-phosphorylated tumor protein p53, and superoxide-dismutase-2 showed a two-fold decrease in expression in the uninvolved skin. Over-representation analysis suggested the Forkhead-box protein O (FOXO)-mediated transcription as the most significant pathway affected by the differently expressed cell-stress-related proteins (DECSRPs). DECSRPs indicate increased FOXO-mediated transcription of cell-cycle genes and reduced interleukin-signaling in the psoriatic uninvolved skin. Nuclear positivity of the FOXO-signaling-related p27/CDKN1B and FOXO1 are negatively correlated with the disease severity and showed increased expression in the uninvolved epidermis and also in healthy primary keratinocytes, which were grown on cartilage oligomeric matrix protein-coated surfaces. Our results indicate a cell-cycle inhibitory process, as a stress-related compensatory mechanism in the uninvolved epidermis, that could be responsible for blocking keratinocyte hyperproliferation in the psoriatic uninvolved skin, thus maintaining the symptomless skin phenotype.

Keywords: FOXO-mediated transcription; cell-stress; p27/CDKN1B; psoriasis; uninvolved skin

References

  1. Br J Dermatol. 2002 Mar;146(3):392-8 - PubMed
  2. Arch Dermatol Res. 2007 Jul;299(4):191-200 - PubMed
  3. Lancet. 2021 Apr 3;397(10281):1301-1315 - PubMed
  4. J Invest Dermatol. 2019 Jul;139(7):1470-1479 - PubMed
  5. J Invest Dermatol. 2004 Sep;123(3):537-46 - PubMed
  6. Front Immunol. 2017 Aug 29;8:1053 - PubMed
  7. J Invest Dermatol. 2000 Apr;114(4):706-11 - PubMed
  8. Br J Dermatol. 2020 Mar;182(3):678-689 - PubMed
  9. J Eur Acad Dermatol Venereol. 2002 May;16(3):241-8 - PubMed
  10. J Invest Dermatol. 2020 Sep;140(9):1733-1742.e7 - PubMed
  11. J Biol Chem. 2005 Jun 24;280(25):24159-67 - PubMed
  12. Mol Biol Rep. 2011 Aug;38(6):4219-24 - PubMed
  13. Oncogene. 2008 Apr 7;27(16):2258-62 - PubMed
  14. Front Immunol. 2019 Jul 31;10:1807 - PubMed
  15. Pflugers Arch. 2016 Jun;468(6):935-43 - PubMed
  16. Dermatol Clin. 1995 Oct;13(4):723-37 - PubMed
  17. Acta Derm Venereol. 2014 Jul;94(4):380-5 - PubMed
  18. Arch Dermatol Res. 1996 Aug;288(9):527-31 - PubMed
  19. Exp Dermatol. 2021 Jun;30(6):765-772 - PubMed
  20. J Dermatol Sci. 1997 Feb;14(2):154-61 - PubMed
  21. Acta Derm Venereol Suppl (Stockh). 1989;146:33-5 - PubMed
  22. J Cell Biochem. 2019 Mar;120(3):3384-3392 - PubMed
  23. Biochem Biophys Res Commun. 2001 Apr 13;282(4):853-60 - PubMed
  24. Dermatol Ther. 2020 Jan;33(1):e13185 - PubMed
  25. J Invest Dermatol. 2001 Dec;117(6):1538-45 - PubMed
  26. Healthcare (Basel). 2021 May 07;9(5): - PubMed
  27. Mol Endocrinol. 2004 Jul;18(7):1756-67 - PubMed
  28. Br J Dermatol. 2016 Mar;174(3):533-41 - PubMed
  29. Exp Dermatol. 2019 Jan;28(1):72-75 - PubMed
  30. J Invest Dermatol. 2000 Nov;115(5):771-7 - PubMed
  31. J Clin Invest. 1995 Jan;95(1):317-27 - PubMed
  32. J Clin Invest. 1992 Jun;89(6):1783-95 - PubMed

Publication Types

Grant support